My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1429 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–11 of 11 startups

ASI

Tracking

American Dynamism

Company website description

Frontier AI to orchestrate critical infrastructure and national security.

Andreessen Horowitz
airspace-intelligence.com ↗
Research ASI

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Frontier AI to orchestrate critical infrastructure and national security.

Visit airspace-intelligence.com ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

American Dynamism

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Asimov

Limited coverage

Bio + Health

RiseFinder summary

Asimov develops tools for genetic design and cell engineering.

Andreessen Horowitz
asimov.com ↗
Research Asimov

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
Rank is outside the reliable comparison range. Waiting for reliable measurements.Last reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Official news source checked. A missing event does not establish inactivity.News checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

Asimov develops tools for genetic design and cell engineering.

Visit asimov.com ↗
Source category

Bio + Health

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Basis

Limited coverage

RiseFinder summary

Basis builds AI agents for work at accounting firms.

AccelKhosla Ventures
getbasis.ai ↗
Research Basis

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

Basis builds AI agents for work at accounting firms.

Visit getbasis.ai ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Defendify, Inc.

Tracking

Other Technology

On its website, the company describes its work as “Defendify offers all-in-one, multi-layered protection that makes robust cybersecurity easier and more accessible. See how it works Industries Manufacturing Distribution Professional Services Healthcare Software E-Commerce…”.

No tracked VC backing recorded
defendify.com ↗
Research Defendify, Inc.

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Tracking
Official news source checked. A missing event does not establish inactivity.News checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Defendify offers all-in-one, multi-layered protection that makes robust cybersecurity easier and more accessible. See how it works Industries Manufacturing Distribution Professional Services Healthcare Software E-Commerce…”.

Visit defendify.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $6,538,000 · Offering amount as filed: $6,538,000

    SEC source checked 8 Nov 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Doxel

Limited coverage

Enterprise

Company website description

Automated construction progress tracking brings actionable insights to executives and makes the job easier for the field.

Andreessen Horowitz
doxel.ai ↗
Research Doxel

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Automated construction progress tracking brings actionable insights to executives and makes the job easier for the field.

Visit doxel.ai ↗Product description source ↗

Product source checked 31 Oct 2026

Source category

Enterprise

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Ibasis

Limited coverage

Company website description

iBASIS is the leading communications solutions provider enabling operators and digital players worldwide to perform and transform.

CRV
ibasis.com ↗
Research Ibasis

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

iBASIS is the leading communications solutions provider enabling operators and digital players worldwide to perform and transform.

Visit ibasis.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

NG.CASH

Tracking

Fintech

RiseFinder summary

NG.CASH offers digital accounts for adults and minors, with a Mastercard, Pix payments, card purchases and features for setting money aside each month.

Andreessen Horowitz
ng.cash ↗
Research NG.CASH

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

NG.CASH offers digital accounts for adults and minors, with a Mastercard, Pix payments, card purchases and features for setting money aside each month.

Visit ng.cash ↗
Source category

Fintech

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Oasis Labs

Limited coverage

Frontier

Product details not available yet.

Andreessen Horowitz
oasislabs.com ↗
Research Oasis Labs

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit oasislabs.com ↗
Source category

Frontier

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Secure Closure, Inc.

Limited coverage

Other Technology

On its website, the company describes its work as “As large-bore minimally invasive therapies become increasingly common in cardiovascular care, the need for reliable femoral vascular closure solutions is more critical than ever. Secure…”.

No tracked VC backing recorded
secure-closure.com ↗
Research Secure Closure, Inc.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “As large-bore minimally invasive therapies become increasingly common in cardiovascular care, the need for reliable femoral vascular closure solutions is more critical than ever. Secure…”.

Visit secure-closure.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $20,000 · Offering amount as filed: $2,000,000

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Switch Therapeutics

Limited coverage

Company website description

Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).

CRV
switchthera.com ↗
Research Switch Therapeutics

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).

Visit switchthera.com ↗Product description source ↗

Product source checked 31 Oct 2026

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Viki

Tracking

RiseFinder summary

Viki streams Asian dramas and films with subtitles.

CRV
viki.com ↗
Research Viki

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

Viki streams Asian dramas and films with subtitles.

Visit viki.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.